Skip to main content
Erschienen in: Journal of Nuclear Cardiology 4/2017

01.08.2017 | Original Article

Sex affects myocardial blood flow and fatty acid substrate metabolism in humans with nonischemic heart failure

verfasst von: Ana Kadkhodayan, MD, C. Huie Lin, MD, PhD, Andrew R. Coggan, PhD, Zulfia Kisrieva-Ware, MD, PhD, Kenneth B. Schechtman, PhD, Eric Novak, MS, Susan M. Joseph, MD, Víctor G. Dávila-Román, MD, Robert J. Gropler, MD, Carmen Dence, MS, Linda R. Peterson, MD, FAHA

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

In animal models of heart failure (HF), myocardial metabolism shifts from high-energy fatty acid (FA) metabolism toward glucose. However, FA (vs glucose) metabolism generates more ATP/mole; thus, FA metabolism may be especially advantageous in HF. Sex modulates myocardial blood flow (MBF) and substrate metabolism in normal humans. Whether sex affects MBF and metabolism in patients with HF is unknown.

Methods and Results

We studied 19 well-matched men and women with nonischemic HF (EF ≤ 35%). MBF and myocardial substrate metabolism were quantified using positron emission tomography. Women had higher MBF (mL/g/minute), FA uptake (mL/g/minute), and FA utilization (nmol/g/minute) (P < 0.005, P < 0.005, P < 0.05, respectively) and trended toward having higher FA oxidation than men (P = 0.09). These findings were independent of age, obesity, and insulin resistance. There were no sex-related differences in fasting myocardial glucose uptake or metabolism. Higher MBF was related to improved event-free survival (HR 0.31, P = 0.02).

Conclusions

In nonischemic HF, women have higher MBF and FA uptake and metabolism than men, irrespective of age, obesity, or insulin resistance. Moreover, higher MBF portends a better prognosis. These sex-related differences should be taken into account in the development and targeting of novel agents aimed at modulating MBF and metabolism in HF.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402.CrossRefPubMed Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-402.CrossRefPubMed
3.
Zurück zum Zitat Kimmelstiel C, Goldberg RJ. Congestive heart failure in women: Focus on heart failure due to coronary artery disease and diabetes. Cardiology 1990;77:71-9.CrossRefPubMed Kimmelstiel C, Goldberg RJ. Congestive heart failure in women: Focus on heart failure due to coronary artery disease and diabetes. Cardiology 1990;77:71-9.CrossRefPubMed
4.
Zurück zum Zitat Kadkhodayan A, Coggan AR, Peterson LR. A “PET” area of interest: Myocardial metabolism in human systolic heart failure. Heart Fail Rev 2013;18:567-74.CrossRefPubMedCentralPubMed Kadkhodayan A, Coggan AR, Peterson LR. A “PET” area of interest: Myocardial metabolism in human systolic heart failure. Heart Fail Rev 2013;18:567-74.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Neglia D, De Caterina A, Marraccini P, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;293:H3270-8.CrossRefPubMed Neglia D, De Caterina A, Marraccini P, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2007;293:H3270-8.CrossRefPubMed
6.
Zurück zum Zitat Taegtmeyer H, Wilson CR, Razeghi P, Sharma S. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 2005;1047:208-18.CrossRefPubMed Taegtmeyer H, Wilson CR, Razeghi P, Sharma S. Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 2005;1047:208-18.CrossRefPubMed
7.
Zurück zum Zitat Peterson LR, Herrero P, McGill J, et al. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 2008;57:32-40.CrossRefPubMed Peterson LR, Herrero P, McGill J, et al. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 2008;57:32-40.CrossRefPubMed
8.
9.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.CrossRefPubMed
10.
Zurück zum Zitat Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 2007;14:573-81.CrossRefPubMedCentralPubMed Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 2007;14:573-81.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Herrero P, Kisrieva-Ware Z, Dence CS, et al. PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling. J Nucl Med 2007;48:955-64.CrossRefPubMed Herrero P, Kisrieva-Ware Z, Dence CS, et al. PET measurements of myocardial glucose metabolism with 1-11C-glucose and kinetic modeling. J Nucl Med 2007;48:955-64.CrossRefPubMed
12.
Zurück zum Zitat Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37:1723-30.PubMed Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med 1996;37:1723-30.PubMed
13.
Zurück zum Zitat de Simone G, Devereux RB, Daniels SR, et al. Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997;95:1837-43.CrossRefPubMed de Simone G, Devereux RB, Daniels SR, et al. Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997;95:1837-43.CrossRefPubMed
14.
Zurück zum Zitat Herrero P, Soto PF, Dence CS, et al. Impact of hormone replacement on myocardial fatty acid metabolism: Potential role of estrogen. J Nucl Cardiol 2005;12:574-81.CrossRefPubMed Herrero P, Soto PF, Dence CS, et al. Impact of hormone replacement on myocardial fatty acid metabolism: Potential role of estrogen. J Nucl Cardiol 2005;12:574-81.CrossRefPubMed
15.
Zurück zum Zitat Kaufmann PA, Rimoldi O, Gnecchi-Ruscone T, Bonser RS, Lüscher TF, Camici PG. Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans. Circulation 2004;110:1431-6.CrossRefPubMed Kaufmann PA, Rimoldi O, Gnecchi-Ruscone T, Bonser RS, Lüscher TF, Camici PG. Systemic inhibition of nitric oxide synthase unmasks neural constraint of maximal myocardial blood flow in humans. Circulation 2004;110:1431-6.CrossRefPubMed
16.
17.
Zurück zum Zitat Peterson LR, Saeed IM, McGill JB, et al. Sex and type 2 diabetes: Obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity 2012;20:802-10.CrossRefPubMed Peterson LR, Saeed IM, McGill JB, et al. Sex and type 2 diabetes: Obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity 2012;20:802-10.CrossRefPubMed
18.
Zurück zum Zitat Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002;40:271-7.CrossRefPubMed Davila-Roman VG, Vedala G, Herrero P, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002;40:271-7.CrossRefPubMed
19.
Zurück zum Zitat Tuunanen H, Engblom E, Naum A, et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: Evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail 2006;12:644-52.CrossRefPubMed Tuunanen H, Engblom E, Naum A, et al. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: Evidence of relationship with insulin resistance and left ventricular dysfunction. J Card Fail 2006;12:644-52.CrossRefPubMed
20.
Zurück zum Zitat Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.CrossRefPubMed Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.CrossRefPubMed
21.
Zurück zum Zitat Bauersachs J, Schafer A. Endothelial dysfunction in heart failure: Mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2004;2:115-24.CrossRefPubMed Bauersachs J, Schafer A. Endothelial dysfunction in heart failure: Mechanisms and therapeutic approaches. Curr Vasc Pharmacol 2004;2:115-24.CrossRefPubMed
22.
Zurück zum Zitat Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999;99:354-60.CrossRefPubMed Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999;99:354-60.CrossRefPubMed
23.
Zurück zum Zitat Peterson LR, Eyster D, Davila-Roman VG, et al. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women. Am Heart J 2001;142:641-7.CrossRefPubMed Peterson LR, Eyster D, Davila-Roman VG, et al. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women. Am Heart J 2001;142:641-7.CrossRefPubMed
24.
Zurück zum Zitat Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 2010;74:1265-73.CrossRefPubMed Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 2010;74:1265-73.CrossRefPubMed
25.
Zurück zum Zitat Herrero P, Kim J, Sharp TL, et al. Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. J Nucl Med 2006;47:477-85.PubMed Herrero P, Kim J, Sharp TL, et al. Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET. J Nucl Med 2006;47:477-85.PubMed
26.
Zurück zum Zitat Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001;4:499-502.CrossRefPubMed Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 2001;4:499-502.CrossRefPubMed
27.
Zurück zum Zitat Kiens B, Roepstorff C, Glatz JF, et al. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: Influence of physical activity and gender. J Appl Physiol 1985;2004:1209-18. Kiens B, Roepstorff C, Glatz JF, et al. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: Influence of physical activity and gender. J Appl Physiol 1985;2004:1209-18.
28.
Zurück zum Zitat Nielsen S, Guo Z, Albu JB, Klein S, O’Brien PC, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 2003;111:981-8.CrossRefPubMedCentralPubMed Nielsen S, Guo Z, Albu JB, Klein S, O’Brien PC, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 2003;111:981-8.CrossRefPubMedCentralPubMed
29.
30.
Zurück zum Zitat Tuunanen H, Engblom E, Naum A, et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 2006;114:2130-7.CrossRefPubMed Tuunanen H, Engblom E, Naum A, et al. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 2006;114:2130-7.CrossRefPubMed
31.
Zurück zum Zitat Kolwicz SCJ, Olson DP, Marney LC, Garcia-Menendez L, Synovec RE, Tian R. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 2012;111:728-38.CrossRefPubMedCentralPubMed Kolwicz SCJ, Olson DP, Marney LC, Garcia-Menendez L, Synovec RE, Tian R. Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 2012;111:728-38.CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat He L, Kim T, Long Q, et al. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 2012;126:1705-16.CrossRefPubMedCentralPubMed He L, Kim T, Long Q, et al. Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity. Circulation 2012;126:1705-16.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: A meta-analysis of randomised controlled trials in heart failure. Heart 2011;97:278-86.CrossRefPubMed Gao D, Ning N, Niu X, Hao G, Meng Z. Trimetazidine: A meta-analysis of randomised controlled trials in heart failure. Heart 2011;97:278-86.CrossRefPubMed
Metadaten
Titel
Sex affects myocardial blood flow and fatty acid substrate metabolism in humans with nonischemic heart failure
verfasst von
Ana Kadkhodayan, MD
C. Huie Lin, MD, PhD
Andrew R. Coggan, PhD
Zulfia Kisrieva-Ware, MD, PhD
Kenneth B. Schechtman, PhD
Eric Novak, MS
Susan M. Joseph, MD
Víctor G. Dávila-Román, MD
Robert J. Gropler, MD
Carmen Dence, MS
Linda R. Peterson, MD, FAHA
Publikationsdatum
01.08.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2017
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0467-6

Weitere Artikel der Ausgabe 4/2017

Journal of Nuclear Cardiology 4/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.